ReposiTrak Announces Track and Trace Agreement
PTSM: Pharmaceutical Technology Sourcing and Management
ReposiTrak signs agreement to pilot track and trace system in pharma.
Park City Group’s ReposiTrak has signed an agreement with a biopharmaceutical manufacturer to pilot ReposiTrak’s Track & Trace solution. ReposiTrak will provide the manufacturer with visibility to product movement through the supply chain and guard against the entry of counterfeit drugs.
Using the company’s Track & Trace system, the biopharmaceutical manufacturer will track the end-to-end movement of items at the lot level. Trading partners will receive alerts to any unauthorized movement or location to ensure product authenticity and eliminate the entry of counterfeits. Once the efficacy of ReposiTrak’s Track & Trace system has been proven, the manufacturer plans to leverage the technology’s scalability and launch a full rollout.
Source: ReposiTrak
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
